NISA INVESTMENT ADVISORS, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$230,342
-81.5%
4,422
-77.5%
0.00%
-77.8%
Q2 2023$1,242,465
+515445.6%
19,622
+341.7%
0.01%
+350.0%
Q1 2023$241
+2.1%
4,442
-0.4%
0.00%0.0%
Q4 2022$236
-99.9%
4,4620.0%0.00%0.0%
Q3 2022$205,000
-12.4%
4,462
+9.1%
0.00%0.0%
Q2 2022$234,000
-17.0%
4,091
-11.3%
0.00%0.0%
Q1 2022$282,000
-33.0%
4,611
-48.0%
0.00%
-33.3%
Q4 2021$421,000
+28.0%
8,869
+0.5%
0.00%
+50.0%
Q3 2021$329,000
-7.3%
8,822
+1.4%
0.00%0.0%
Q2 2021$355,000
+20.3%
8,7000.0%0.00%0.0%
Q1 2021$295,000
+6.5%
8,7000.0%0.00%0.0%
Q4 2020$277,000
+44.3%
8,700
+16.4%
0.00%0.0%
Q3 2020$192,000
-27.5%
7,475
-27.6%
0.00%0.0%
Q2 2020$265,000
+75.5%
10,322
+4.8%
0.00%0.0%
Q1 2020$151,000
-53.1%
9,850
+5.0%
0.00%
-33.3%
Q4 2019$322,000
+360.0%
9,3800.0%0.00%
+200.0%
Q3 2019$70,000
+775.0%
9,380
+1776.0%
0.00%
Q3 2016$8,000
-57.9%
5000.0%0.00%
Q2 2016$19,000
+35.7%
5000.0%0.00%
Q1 2016$14,0005000.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders